Japan Pen Needles Market (2024-2029)
The Japan Pen Needles Market was valued at $101.54 Million in 2024 and projected to reach to $172.4 Million by 2029, representing a compound annual growth rate of 9.2%. Japan's pen needles market is poised for sustained growth through 2029, driven by the convergence of an aging population, rising diabetes incidence, and strong healthcare infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Pen Needles Market Trends and Insights
- This expansion reflects Japan's aging population and rising prevalence of diabetes, which drives demand for convenient insulin delivery devices.
- Japan's advanced healthcare infrastructure and high adoption of injectable therapies position the country as a significant market within Asia Pacific. The pen needles market in Japan is supported by increasing patient preference for self-administered injectable medications and growing awareness of diabetes management.
- Japan's regulatory environment and strong pharmaceutical distribution networks facilitate market penetration of innovative pen needle products.
- Between 2024 and 2029, Japan is expected to maintain steady growth momentum, driven by demographic shifts and improved access to diabetes care across urban and rural regions..
Key Market Statistics
- CAGR (2024-2029) 9.2% CAGR
- Market Size, 2024 ~USD 101.54 Million
- Forecast, 2029 ~USD 172.4 Million
- Country Japan
Japan Pen Needles Market Overview
Aging Population Driving Demand :
Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases diabetes prevalence and insulin dependency, directly boosting pen needle consumption across the country.
Advanced Healthcare Infrastructure :
Japan's world-class healthcare system and high insurance coverage rates facilitate widespread adoption of premium injectable diabetes management devices, supporting market growth and premium product penetration.
Strong CAGR of 9.2% :
Japan's pen needles market is projected to grow from $101.54 million in 2024 to $172.4 million by 2029, reflecting consistent double-digit expansion driven by lifestyle changes and improved disease awareness.
High Adoption of Injectable Therapies :
Japanese patients and healthcare providers show strong preference for injectable insulin and GLP-1 therapies, positioning pen needles as essential consumables in the country's diabetes management ecosystem.
Japan Pen Needles Market Dynamics
- The country's emphasis on preventive care and advanced medical technologies creates a favorable environment for premium pen needle products.
- Additionally, increasing awareness of diabetes management among healthcare professionals and patients will accelerate adoption rates.
- Market expansion will be supported by continuous product innovations and the integration of digital health solutions in diabetes care management..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Japan's pen needles market is valued at $101.54 million in 2024 and will reach $172.4 million by 2029, representing a 9.2% CAGR.
- Japan's aging demographic and high diabetes prevalence are primary drivers of sustained market expansion through 2029.
- Japan's advanced healthcare infrastructure and strong regulatory framework support rapid adoption of innovative pen needle technologies.
- Patient preference for convenient self-administered injectable therapies continues to fuel growth in Japan's pen needles market.
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Japan Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GLP-1 THERAPY | 6.31 | 6.58 | 7.04 | 7.62 | 8.27 | 9.82 | 10.76 | 11.83 | 9 |
| GROWTH HORMONE THERAPY | 1.8 | 1.81 | 1.86 | 1.93 | 2.02 | 2.22 | 2.34 | 2.47 | 4.9 |
| INSULIN THERAPY | 85.23 | 89.74 | 96.88 | 105.89 | 116.01 | 140.53 | 155.43 | 172.51 | 10.1 |
| OSTEOPOROSIS | 4.99 | 5.19 | 5.52 | 5.95 | 6.43 | 7.57 | 8.26 | 9.04 | 8.6 |
| OTHER APPLICATIONS | 8.54 | 8.73 | 9.15 | 9.7 | 10.32 | 11.78 | 12.64 | 13.62 | 6.9 |
| TOTAL | 106.88 | 112.05 | 120.44 | 131.09 | 143.05 | 171.92 | 189.43 | 209.47 | 9.7 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Japan-specific market data to develop localized product strategies, assess market entry feasibility, and benchmark competitive positioning in this high-value healthcare market.
- Healthcare Investors & PE Firms : Investors require detailed Japan market analysis to evaluate investment opportunities, assess growth potential, and make informed capital allocation decisions in the diabetes care sector.
- Pharmaceutical & Diabetes Care Companies : Companies need comprehensive Japan market insights to align insulin and GLP-1 product launches with pen needle demand, optimize supply chain planning, and maximize market penetration.
- Healthcare Consultants & Advisors : Consultants require Japan-specific market data to provide strategic recommendations to clients, support business case development, and guide market expansion initiatives in the region.
- Hospital & Clinic Administrators : Healthcare facility leaders need market intelligence to optimize procurement strategies, forecast inventory requirements, and ensure cost-effective supply of pen needles for diabetic patient populations.
Key Companies in the Japan Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Reasons to Buy this Report
- Market Size & Growth Validation : Access precise market valuation data for Japan ($101.54M in 2024) with verified 9.2% CAGR projections through 2029, enabling accurate financial forecasting and investment decision-making.
- Japan-Specific Demographic Insights : Understand how Japan's unique aging population structure and diabetes epidemiology directly impact pen needle demand, allowing for targeted market entry and product positioning strategies.
- Competitive Landscape Intelligence : Gain detailed analysis of Japan's healthcare infrastructure, insurance dynamics, and provider preferences to identify competitive advantages and market differentiation opportunities specific to the region.
- Regulatory & Reimbursement Framework : Obtain comprehensive insights into Japan's medical device regulations, pricing controls, and insurance reimbursement policies essential for successful market penetration and profitability planning.
- Strategic Growth Opportunities : Identify high-potential segments within Japan's market, including emerging patient demographics, underserved regions, and innovative product categories aligned with local healthcare trends.
Frequently asked questions
What is the current size of Japan's pen needles market?
Japan's pen needles market was valued at $101.54 million in 2024 and is projected to grow to $172.4 million by 2029.
What is the expected growth rate for pen needles in Japan?
Japan's pen needles market is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2029.
What factors are driving growth in Japan's pen needles market?
Key drivers include Japan's aging population, rising diabetes prevalence, patient preference for self-administered therapies, and advanced healthcare infrastructure.
How does Japan's pen needles market compare to other Asia Pacific countries?
Japan represents a significant and mature market within Asia Pacific, characterized by high healthcare spending, strong regulatory standards, and advanced distribution networks.
What role does Japan's healthcare system play in pen needles adoption?
Japan's universal healthcare coverage, robust pharmaceutical distribution, and emphasis on diabetes management support widespread adoption and accessibility of pen needle products.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
